Description
AZD-8931isaninhibitorofEGFR,HER2,andHER3thatexhibitsanticancerchemotherapeuticactivity.Invitroandinvivo,AZD-8931suppressesgrowthofinflammatorybreastcancercellsandtumorsandinducesapoptosis.Thiscompoundalsoinhibitsgrowthincellularmodelsofnon-smallcelllungcancer(NSCLC)andsquamouscellcarcinoma.
References
MuZ,KlinowskaT,DongX,etal.AZD8931,anequipotent,reversIBLeinhibitorofsignalingbyepidermalgrowthfactorreceptor(EGFR),HER2,andHER3:preclinicalactivityinHER2non-amplifiedinflammatorybreastcancermodels.JExpClinCancerRes.2014May30;33:47.PMID:24886365.
TjulandinS,MoiseyenkoV,SemiglazovV,etal.PhaseI,dose-findingstudyofAZD8931,aninhibitorofEGFR(erbB1),HER2(erbB2)andHER3(erbB3)signaling,inpatientswithadvancedsolidtumors.InvestNewDrugs.2014Feb;32(1):145-53.PMID:23589215.
HickinsonDM,KlinowskaT,SpeakeG,etal.AZD8931,anequipotent,reversibleinhibitorofsignalingbyepidermalgrowthfactorreceptor,ERBB2(HER2),andERBB3:auniqueagentforsimultaneousERBBreceptorblockadeincancer.ClinCancerRes.2010Feb15;16(4):1159-69.PMID:20145185.